Stay updated on Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record history now lists a new revision entry for v3.5.5. The previous revision v3.5.4 has been removed from the history display.
    Difference
    0.1%
    Check dated 2026-06-05T17:53:25.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    New revision v3.5.4 appears in the Record History, replacing v3.5.3 and signaling a newer version of the record.
    Difference
    0.1%
    Check dated 2026-05-15T07:45:47.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision indicator updates from v3.5.2 to v3.5.3, reflecting a change in the site’s current software version rather than the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T06:24:12.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; Deleted revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:27.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 on the Record History page.
    Difference
    0.1%
    Check dated 2026-03-19T04:49:32.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added revision v3.4.3 to the Record History and removed revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:34:15.000Z thumbnail image

Stay in the know with updates to Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.